430 related articles for article (PubMed ID: 17943815)
1. Taxanes for adjuvant treatment of early breast cancer.
Ferguson T; Wilcken N; Vagg R; Ghersi D; Nowak AK
Cochrane Database Syst Rev; 2007 Oct; (4):CD004421. PubMed ID: 17943815
[TBL] [Abstract][Full Text] [Related]
2. Taxanes for adjuvant treatment of early breast cancer.
Willson ML; Burke L; Ferguson T; Ghersi D; Nowak AK; Wilcken N
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD004421. PubMed ID: 31476253
[TBL] [Abstract][Full Text] [Related]
3. Taxane-containing regimens for metastatic breast cancer.
Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
[TBL] [Abstract][Full Text] [Related]
4. Taxane containing regimens for metastatic breast cancer.
Ghersi D; Wilcken N; Simes J; Donoghue E
Cochrane Database Syst Rev; 2005 Apr; (2):CD003366. PubMed ID: 15846659
[TBL] [Abstract][Full Text] [Related]
5. Taxane containing regimens for metastatic breast cancer.
Ghersi D; Wilcken N; Simes J; Donoghue E
Cochrane Database Syst Rev; 2003; (3):CD003366. PubMed ID: 12917963
[TBL] [Abstract][Full Text] [Related]
6. Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.
Ward S; Simpson E; Davis S; Hind D; Rees A; Wilkinson A
Health Technol Assess; 2007 Oct; 11(40):1-144. PubMed ID: 17903394
[TBL] [Abstract][Full Text] [Related]
7. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab-containing regimens for metastatic breast cancer.
Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
[TBL] [Abstract][Full Text] [Related]
9. Single agent versus combination chemotherapy for metastatic breast cancer.
Carrick S; Parker S; Wilcken N; Ghersi D; Marzo M; Simes J
Cochrane Database Syst Rev; 2005 Apr; (2):CD003372. PubMed ID: 15846660
[TBL] [Abstract][Full Text] [Related]
10. Platinum-containing regimens for metastatic breast cancer.
Egger SJ; Willson ML; Morgan J; Walker HS; Carrick S; Ghersi D; Wilcken N
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003374. PubMed ID: 28643430
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis.
Fujii T; Le Du F; Xiao L; Kogawa T; Barcenas CH; Alvarez RH; Valero V; Shen Y; Ueno NT
JAMA Oncol; 2015 Dec; 1(9):1311-8. PubMed ID: 26402167
[TBL] [Abstract][Full Text] [Related]
12. Platinum containing regimens for metastatic breast cancer.
Carrick S; Ghersi D; Wilcken N; Simes J
Cochrane Database Syst Rev; 2004; (2):CD003374. PubMed ID: 15106201
[TBL] [Abstract][Full Text] [Related]
13. Antitumour antibiotic containing regimens for metastatic breast cancer.
Lord S; Ghersi D; Gattellari M; Wortley S; Wilcken N; Simes J
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD003367. PubMed ID: 15495049
[TBL] [Abstract][Full Text] [Related]
14. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.
;
Lancet; 2023 Apr; 401(10384):1277-1292. PubMed ID: 37061269
[TBL] [Abstract][Full Text] [Related]
15. Platinum containing regimens for metastatic breast cancer.
Carrick S; Ghersi D; Wilcken N; Simes J
Cochrane Database Syst Rev; 2004; (3):CD003374. PubMed ID: 15266482
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.
Caparica R; Bruzzone M; Poggio F; Ceppi M; de Azambuja E; Lambertini M
Breast Cancer Res Treat; 2019 Feb; 174(1):27-37. PubMed ID: 30465156
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer.
Nowak AK; Wilcken NR; Stockler MR; Hamilton A; Ghersi D
Lancet Oncol; 2004 Jun; 5(6):372-80. PubMed ID: 15172358
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients.
Qin YY; Li H; Guo XJ; Ye XF; Wei X; Zhou YH; Zhang XJ; Wang C; Qian W; Lu J; He J
PLoS One; 2011; 6(11):e26946. PubMed ID: 22069477
[TBL] [Abstract][Full Text] [Related]
20. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.
Jones D; Ghersi D; Wilcken N
Cochrane Database Syst Rev; 2006 Jul; (3):CD003368. PubMed ID: 16856005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
